Dr. Christian Lattermann, director for Cartilage Repair and Restoration in the University of Kentucky Department of Orthopaedic Surgery and Sports Medicine, recently became the first person at UK HealthCare — as well as in Kentucky and in the Midwest — to perform a Matrix Associated Chondrocyte Implantation (MACI). The technology for this new procedures constitutes the first, and only new, cartilage technology to be approved by the U.S. Food and Drug Administration (FDA) since 1996.
The new MACI technology utilizes the patients’ own cartilage cells to create the MACI scaffold which, unlike preceding technology, can be glued into the cartilage defect. This technique can therefore be done through smaller incisions with a significant improvement in operating time and an easier path to recovery, said Latterman. This technology is new in the United States but has an almost 10 year track record in Europe with excellent results.
On Feb. 15, Victoria Long was the first patient to receive this treatment at UK. An 18-year-old student who had suffered from a cartilage loss in the knee as a consequence of multiple falls onto her knee cap, Long had been experiencing pain for over a year and had been receiving non-operative treatment during that time. At her follow-up... FULL STORY